Frank Qian

1 week ago | pharmacytimes.com | Frank Qian |Alana Hippensteele

CommentaryVideoJune 1, 2025Author(s):,Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns. As interest in omega-3 fatty acids continues to grow, so do questions about their clinical applications, safety, and efficacy.

1 week ago | pharmacytimes.com | Frank Qian |Alana Hippensteele

CommentaryVideoMay 31, 2025Author(s):,Frank Qian, MD, MPH, discusses the clinical indications, dosing strategies, and cardiovascular outcomes data for prescription omega-3 fatty acids, including the ongoing debate about EPA vs EPA-DHA formulations and the implications of recent trial findings. Omega-3 fatty acids have long been recognized for their role in lipid management, but their clinical applications, particularly for cardiovascular risk reduction, continue to evolve.